361
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluation

CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarction

, , &
Pages 997-1005 | Received 13 Jul 2018, Accepted 23 Oct 2018, Published online: 03 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Amit Rout, Ajaypaul Sukhi, Rahul Chaudhary, Kevin P Bliden, Udaya S Tantry & Paul A Gurbel. (2020) Investigational drugs in phase II clinical trials for acute coronary syndromes. Expert Opinion on Investigational Drugs 29:1, pages 33-47.
Read now

Articles from other publishers (15)

Minzhi Yu, Kristen Hong Dorsey, Troy Halseth & Anna Schwendeman. (2023) Enhancement of Anti-inflammatory Effects of Synthetic High-Density Lipoproteins by Incorporation of Anionic Lipids. Molecular Pharmaceutics 20:11, pages 5454-5462.
Crossref
Luis Ortega-Paz, Salvatore Giordano, Davide Capodanno, Roxana Mehran, C. Michael Gibson & Dominick J. Angiolillo. (2023) Clinical Pharmacokinetics and Pharmacodynamics of CSL112. Clinical Pharmacokinetics 62:4, pages 541-558.
Crossref
Kui Cui, Xinlei GaoBeibei WangHao WuKulandaisamy Arulsamy, Yunzhou DongYuling XiaoXingya JiangMarina V. MalovichkoKathryn LiQianman Peng, Yao Wei Lu, Bo ZhuRongbin ZhengScott WongDouglas B. Cowan, MacRae Linton, Sanjay SrivastavaJinjun Shi, Kaifu Chen & Hong Chen. (2023) Epsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression. Circulation Research 132:1.
Crossref
Sunil A. Nankar, Priyanka S. Kawathe & Abhay H. Pande. (2022) HDL, ApoA-I and ApoE-Mimetic Peptides: Potential Broad Spectrum Agent for Clinical Use?. International Journal of Peptide Research and Therapeutics 28:2.
Crossref
Haoyu Wu, Chen Wang, Gulinigaer Tuerhongjiang, Xiangrui Qiao, Yiming Hua, Jianqing She & Zuyi Yuan. (2023) Circulating lipid and lipoprotein profiles and their correlation to cardiac function and cardiovascular outcomes in patients with acute myocardial infarction. Journal of Investigative Medicine 69:7, pages 1310-1317.
Crossref
Bo Zheng, Danielle Duffy, Pierluigi Tricoci, Helen Kastrissios, Marc Pfister, Samuel D. Wright, Andreas Gille & Michael A. Tortorici. (2020) Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A‐I and cholesterol efflux capacity in acute myocardial infarction patients. British Journal of Clinical Pharmacology 87:6, pages 2558-2571.
Crossref
Aditya Gupta, Reena Sharma, Kaushik Kuche & Sanyog Jain. (2021) Exploring the therapeutic potential of the bioinspired reconstituted high density lipoprotein nanostructures. International Journal of Pharmaceutics 596, pages 120272.
Crossref
Natalie C. Ward & Gerald F. Watts. 2021. Therapeutic Lipidology. Therapeutic Lipidology 615 636 .
Himani Thakkar, Vinnyfred Vincent, Ambuj Roy, Sandeep Singh, Lakshmy Ramakrishnan, Mani Kalaivani & Archna Singh. (2020) HDL functions and their interaction in patients with ST elevation myocardial infarction: a case control study. Lipids in Health and Disease 19:1.
Crossref
Soumaya Ben-Aicha, Laura Casaní, Natàlia Muñoz-García, Oriol Joan-Babot, Esther Peña, Monika Aržanauskaitė, Manuel Gutierrez, Guiomar Mendieta, Teresa Padró, Lina Badimon & Gemma Vilahur. (2020) HDL (High-Density Lipoprotein) Remodeling and Magnetic Resonance Imaging–Assessed Atherosclerotic Plaque Burden. Arteriosclerosis, Thrombosis, and Vascular Biology 40:10, pages 2481-2493.
Crossref
Devinder S. Dhindsa, Pratik B. Sandesara, Michael D. Shapiro & Nathan D. Wong. (2020) The Evolving Understanding and Approach to Residual Cardiovascular Risk Management. Frontiers in Cardiovascular Medicine 7.
Crossref
Rafique Islam, Denis O. Sviridov, Steven K. Drake, Jude Tunyi, Galina Abdoulaeva, Lita A. Freeman, Richard W. Pastor & Alan T. Remaley. (2020) Incorporation of α-methylated amino acids into Apolipoprotein A-I mimetic peptides improves their helicity and cholesterol efflux potential. Biochemical and Biophysical Research Communications 526:2, pages 349-354.
Crossref
Soumaya Ben-Aicha, Lina Badimon & Gemma Vilahur. (2020) Advances in HDL: Much More than Lipid Transporters. International Journal of Molecular Sciences 21:3, pages 732.
Crossref
David Castaño, Chutima Rattanasopa, Vera F. Monteiro-Cardoso, Maria Corlianò, Yiran Liu, Shiqi Zhong, Mihaela Rusu, Elisa A. Liehn & Roshni R. Singaraja. (2020) Lipid efflux mechanisms, relation to disease and potential therapeutic aspects. Advanced Drug Delivery Reviews 159, pages 54-93.
Crossref
Johanne Silvain, Mathieu Kerneis, Maryse Guerin & Gilles Montalescot. (2019) Modulation of cholesterol efflux capacity in patients with myocardial infarction. Current Opinion in Cardiology 34:6, pages 714-720.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.